Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on June 23, 2020. The report discloses the execution of Severance Agreements with four executive officers, approved by the Board of Directors on the same date.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The material change reported is the establishment of new severance terms for the following executives: Lisa A. Conte (CEO), Steven R. King (Chief of Sustainable Supply), Carol R. Lizak (SVP of Finance), and Jonathan S. Wolin (Chief of Staff). These agreements are triggered by termination without Cause or Good Reason within three months following a Change in Control.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, financial outlook, or general management commentary regarding business operations. The primary disclosure details the terms of the Severance Agreements, which include:
- Severance payment equal to twelve months of base salary (payable as a lump sum or over twelve months).
- Payment of health insurance premiums for twelve months post-termination.
- Full acceleration of unvested stock options and restricted stock units upon termination.
- Extension of the exercise period for vested stock options to one year post-termination.
Receipt of these benefits is contingent upon the execution of a release agreement by the executive officer.
Investor Verification Checklist
- Verify the specific base salary amounts for the named executives to calculate potential severance liabilities.
- Review the full text of the Form of Severance Agreement filed as an exhibit to the 10-Q for the quarter ended June 30, 2020.
- Confirm the current vesting status of stock options and restricted stock units held by the named officers.
- Monitor for any announcements regarding a Change in Control that would activate these agreements.